You just read:

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Advanced Solid Tumors

News provided by

Infinity Pharmaceuticals, Inc.

Nov 09, 2016, 06:59 ET